Rand Corporation

• 

  FDA approves generic Plan B contraceptive

  By Jenny Ivy  |  July 13, 2012

  The Food and Drug Administration has approved a generic version of Teva Women's Health's Plan B One-Step, an emergency contraceptive that is availble over-the-couter without a prescription for women age 17 and older.

• 401(k) strategies even the lazy can love

  By Danielle Andrus, AdvisorOne  |  March 27, 2012

  The key to boosting retirement savings is putting much of the process on autopilot, according to Robert Kaplan, vice president of ING's U.S. Retirement Services.

• Most small biz owners won’t opt out of health reform

  By Kathryn Mayer  |  February 23, 2012

  Rules that allow some small employers to avoid regulation under health reform are unlikely to have a major impact on the future cost of health insurance unless those rules are relaxed to allow more businesses to opt out.

• 

  Generics ease financial burdens

  By Kathryn Mayer  |  February 22, 2012

  Thanks to greater use of generic drugs, the financial burden Americans face with prescription drug use has declined, says a study from the RAND Corporation.

• McKinsey’s story starts to crumble

  By Kathryn Mayer  |  June 16, 2011

  Another day, another wave of controversy over the McKinsey report.

• Study: Nobody's a special risk in high-deductibles

  By Jenny Ivy  |  April 18, 2011

  A recent study finds low-income and medically vulnerable high-deductible plan enrollees are just as likely to cut back on needed health care as other HDP enrollees.